Top 5 Takeaways Significant Increase in Intracranial Infections: During the first two years of the COVID-19 pandemic, an increase in pediatric intracranial infections was observed, with cases often diagnosed during
Tag: COVID
Top 5 Takeaways Higher Risk for Specific Conditions: Children and adolescents with previous COVID-19 showed higher rates of acute pulmonary embolism, myocarditis and cardiomyopathy, venous thromboembolic event, acute and unspecified
Top 5 Takeaways Surge in Pediatric COVID-19 Cases: During the 2021–22 school year, New York reported a total of 702,686 COVID-19 cases among children aged 5–17, with a significant increase
Top 5 Takeaways Significant Reporting Disparity: During the study period, 10.7 million self-test results were reported compared to 361.9 million laboratory-based and point-of-care test results, highlighting a vast underreporting of
Top 5 Takeaways Strategic Public Health Recommendations: Emphasis on vaccination and therapeutics to prevent severe illness, complemented by nonpharmaceutical interventions for exposure risk reduction and focus on high-risk individuals. Vaccination
Top 5 Takeaways Higher Incidence and Mortality in Public Transportation: Public transportation industries in California had 1.5 times the cumulative COVID-19 outbreak incidence and mortality rates compared to all industries,
Top 5 Takeaways Similar Adverse Reaction Frequencies: Children aged 5–11 years reported local and systemic reactions to the Pfizer-BioNTech COVID-19 vaccine booster dose with similar frequency as after the second
Top 5 Takeaways Significant Increase in Hospitalizations Among Older Adults: During the Omicron BA.2 variant predominance, hospitalization rates among adults aged ≥65 years showed a threefold increase, highlighting the heightened
Top 5 Takeaways Variability in Long COVID Prevalence: The age- and sex-standardized prevalence of Long COVID among adults varies significantly across U.S. states and territories, ranging from 1.9% in the
Top 5 Takeaways Booster Dose Uptake: Approximately half of the eligible population aged ≥5 years (106.3 million out of 214.4 million) received a COVID-19 vaccine booster dose. Second Booster Dose: